Josephine Emole is an Oncology physician affiliated with Henry Ford Health. OpenAlex indexes 48 publications with 208 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd # K-13
Detroit, MI 482022608
Telephone
800-653-6568Provider last certified this registry record 8 Jan 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Kite Pharma, Inc.Program year20251 payment
- Kite Pharma, Inc.Program year20242 payments
- Kite Pharma, Inc.Program year202311 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
28.2%Osmotically acting laxatives17.4%Magnesium Sulfate100%Part D<11 patientsProton pump inhibitor10.8%Omeprazole100%Part D<11 patientsAnti-infectives
19.5%Penicillin-class Antibacterial12.8%Penicillin V Potassium100%Part D<11 patientsCytomegalovirus DNA Terminase Complex Inhibitor6.7%Prevymis100%Part D<11 patientsDermatology
19%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor19%Acyclovir100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tocilizumab Prophylaxis Following Idecabtagene Vicleucel in the Outpatient Setting in Patients with Relapsed or Refractory Multiple Myeloma
Biology of Blood and Marrow Transplantation
2026 - CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study
Biology of Blood and Marrow Transplantation
2026 - Influence of Ptcy on Lymphopenia Following Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
2026 - Post-Transplant Cyclophosphamide and Urinary-Derived Human Chorionic Gonadotropin and Epidermal Growth Factor (uhCG/EGF) As Graft Versus Host Disease Prophylaxis for Mismatched Unrelated Donor Transplantation: A Phase I Dose Escalation Study (PTCY2HCG3)
Biology of Blood and Marrow Transplantation
2026 - Flu/Mel/TBI Peripheral Blood Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide and Bortezomib (Cy2Bor3): A Pilot Study
Biology of Blood and Marrow Transplantation
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Philip, MD
Henry Ford Health
David Lanfear, MD
Henry Ford Health
Marvin Eng, MD
Henry Ford Health
Karthikeyan Ananthasubramaniam, MD
Henry Ford Health
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”